Assessment of reproducibility in depletion and enrichment workflows for plasma proteomics using label-free quantitative data-independent LC-MS

Proteomics

Volumn 14, Issue 1, 2014, Pages 4-13

  Hakimi, Amirmansoor ^a   Auluck, Janica ^a,b   Jones, George D D ^a   Ng, Leong L ^b   Jones, Donald J L ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b GLENFIELD HOSPITAL   (United Kingdom)

Author keywords

Enrichment; Immunodepletion; Label free LCMS; Plasma; Reproducibility; Technology

Indexed keywords

PLASMA PROTEIN;

ARTICLE; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEPLETION; PROTEOMICS; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; WORKFLOW;

ENRICHMENT; IMMUNODEPLETION; LABEL-FREE LCMS; PLASMA; REPRODUCIBILITY; TECHNOLOGY;

BLOOD PROTEINS; CHROMATOGRAPHY, LIQUID; HUMANS; MASS SPECTROMETRY; PROTEOME; PROTEOMICS; REPRODUCIBILITY OF RESULTS;

EID: 84892403340     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201200563     Document Type: Article

References (50)

1. Hortin, G. L., Sviridov, D., The dynamic range problem in the analysis of the plasma proteome. J. Proteomics 2010, 73, 629-636.
2. Schiess, R., Wollscheid, B., Aebersold, R., Targeted proteomic strategy for clinical biomarker discovery. Mol. Oncol. 2009, 3, 33-44.
3. Oesterling, J. E., Jacobsen, S. J., Chute, C. G., Guess, H. A. et al., Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges. JAMA 1993, 270, 860-864.
4. Anderson, N. L., Anderson, N. G., The human plasma proteome: history, character, and diagnostic prospects. Mol. Cell. Proteomics 2002, 1, 845-867.
5. Tu, C., Rudnick, P. A., Martinez, M. Y., Cheek, K. L. et al., Depletion of abundant plasma proteins and limitations of plasma proteomics. J. Proteome Res. 2010, 9, 4982-4991.
6. Bjorhall, K., Miliotis, T., Davidsson, P., Comparison of different depletion strategies for improved resolution in proteomic analysis of human serum samples. Proteomics 2005, 5, 307-317.
7. Echan, L. A., Tang, H. Y., Ali-Khan, N., Lee, K., Speicher, D. W., Depletion of multiple high-abundance proteins improves protein profiling capacities of human serum and plasma. Proteomics 2005, 5, 3292-3303.
8. Hu, S., Loo, J. A., Wong, D. T., Human body fluid proteome analysis. Proteomics 2006, 6, 6326-6353.
9. Roche, S., Tiers, L., Provansal, M., Seveno, M. et al., Depletion of one, six, twelve or twenty major blood proteins before proteomic analysis: the more the better? J. Proteomics 2009, 72, 945-951.
10. Koutroukides, T. A., Guest, P. C., Leweke, F. M., Bailey, D. M. et al., Characterization of the human serum depletome by label-free shotgun proteomics. J. Sep. Sci. 2011, 34, 1621-1626.
11. Yadav, A. K., Bhardwaj, G., Basak, T., Kumar, D. et al., A systematic analysis of eluted fraction of plasma post immunoaffinity depletion: implications in biomarker discovery. PLoS One 2011, 6, e24442.
12. Merrifield, R. B., Stewart, J. M., Automated peptide synthesis. Nature 1965, 207, 522-523.
13. Lam, K. S., Salmon, S. E., Hersh, E. M., Hruby, V. J. et al., A new type of synthetic peptide library for identifying ligand-binding activity. Nature 1991, 354, 82-84.
14. Furka, A., Sebestyen, F., Asgedom, M., Dibo, G., General method for rapid synthesis of multicomponent peptide mixtures. Int. J. Pept. Protein Res. 1991, 37, 487-493.
15. Thulasiraman, V., Lin, S., Gheorghiu, L., Lathrop, J. et al., Reduction of the concentration difference of proteins in biological liquids using a library of combinatorial ligands. Electrophoresis 2005, 26, 3561-3571.
16. Righetti, P. G., Boschetti, E., Sherlock Holmes and the proteome-a detective story. FEBS J. 2007, 274, 897-905.
17. Righetti, P. G., Boschetti, E., Zanella, A., Fasoli, E., Citterio, A., Plucking, pillaging and plundering proteomes with combinatorial peptide ligand libraries. J. Chromatogr. A 2010, 1217, 893-900.
18. Boschetti, E., Lomas, L., Citterio, A., Righetti, P. G., Romancing the "hidden proteome", Anno Domini two zero zero seven. J. Chromatogr. A 2007, 1153, 277-290.
19. Sala, M., Cordier, S., Chang-Claude, J., Donato, F. et al., Coffee consumption and bladder cancer in nonsmokers: a pooled analysis of case-control studies in European countries. Cancer Causes Control 2000, 11, 925-931.
20. Villanueva, C. M., Cantor, K. P., King, W. D., Jaakkola, J. J. et al., Total and specific fluid consumption as determinants of bladder cancer risk. Int. J. Cancer 2006, 118, 2040-2047.
21. Ong, S. E., Blagoev, B., Kratchmarova, I., Kristensen, D. B. et al., Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. Cell. Proteomics 2002, 1, 376-386.
22. Gerber, S. A., Rush, J., Stemman, O., Kirschner, M. W., Gygi, S. P., Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS. Proc. Natl. Acad. Sci. U.S.A. 2003, 100, 6940-6945.
23. Ross, P. L., Huang, Y. N., Marchese, J. N., Williamson, B. et al., Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol. Cell. Proteomics 2004, 3, 1154-1169.
24. Michalski, A., Cox, J., Mann, M., More than 100, 000 detectable peptide species elute in single shotgun proteomics runs but the majority is inaccessible to data-dependent LCâ̂′MS/MS. J. Proteome Res. 2011, 10, 1785-1793.
25. Silva, J. C., Gorenstein, M. V., Li, G. Z., Vissers, J. P., Geromanos, S. J., Absolute quantification of proteins by LCMSE: a virtue of parallel MS acquisition. Mol. Cell. Proteomics 2006, 5, 144-156.
26. Patel, V. J., Thalassinos, K., Slade, S. E., Connolly, J. B. et al., A comparison of labeling and label-free mass spectrometry-based proteomics approaches. J. Proteome Res. 2009, 8, 3752-3759.
27. Li, G. Z., Vissers, J. P., Silva, J. C., Golick, D. et al., Database searching and accounting of multiplexed precursor and product ion spectra from the data independent analysis of simple and complex peptide mixtures. Proteomics 2009, 9, 1696-1719.
28. Levin, Y., Schwarz, E., Wang, L., Leweke, F. M., Bahn, S., Label-free LC-MS/MS quantitative proteomics for large-scale biomarker discovery in complex samples. J. Sep. Sci. 2007, 30, 2198-2203.
29. Pieper, R., Su, Q., Gatlin, C. L., Huang, S. T. et al., Multi-component immunoaffinity subtraction chromatography: an innovative step towards a comprehensive survey of the human plasma proteome. Proteomics 2003, 3, 422-432.
30. Dwivedi, R. C., Krokhin, O. V., Cortens, J. P., Wilkins, J. A., Assessment of the reproducibility of random hexapeptide peptide library-based protein normalization. J. Proteome Res. 2010, 9, 1144-1149.
31. Millioni, R., Tolin, S., Puricelli, L., Sbrignadello, S. et al., High abundance proteins depletion vs low abundance proteins enrichment: comparison of methods to reduce the plasma proteome complexity. PLoS One 2011, 6, e19603.
32. Gu, S. Z., Zhao, X. H., Quan, P., Li, S. B., Pan, B. R., Alterations of serum cholinesterase in patients with gastric cancer. World J. Gastroenterol. 2005, 11, 4604-4606.
33. Brock, A., Brock, V., Plasma cholinesterase activity in a healthy population group with no occupational exposure to known cholinesterase inhibitors: relative influence of some factors related to normal inter- and intra-individual variations. Scand. J. Clin. Lab. Invest. 1990, 50, 401-408.
34. Kang, U. B., Ahn, Y., Lee, J. W., Kim, Y. H. et al., Differential profiling of breast cancer plasma proteome by isotope-coded affinity tagging method reveals biotinidase as a breast cancer biomarker. BMC Cancer 2010, 10, 114.
35. Farrah, T., Deutsch, E. W., Omenn, G. S., Campbell, D. S. et al., A high-confidence human plasma proteome reference set with estimated concentrations in PeptideAtlas. Mol. Cell. Proteomics 2011, 10, M110.006353.
36. Chee, J., Naran, A., Misso, N. L., Thompson, P. J., Bhoola, K. D., Expression of tissue and plasma kallikreins and kinin B1 and B2 receptors in lung cancer. Biol. Chem. 2008, 389, 1225-1233.
37. Hortin, G. L., Sviridov, D., Anderson, N. L., High-abundance polypeptides of the human plasma proteome comprising the top 4 logs of polypeptide abundance. Clin. Chem. 2008, 54, 1608-1616.
38. Miyazawa, K., Hepatocyte growth factor activator (HGFA): a serine protease that links tissue injury to activation of hepatocyte growth factor. FEBS J. 2010, 277, 2208-2214.
39. Kim, E., Li, K., Lieu, C., Tong, S. et al., Expression of apolipoprotein C-IV is regulated by Ku antigen/peroxisome proliferator-activated receptor gamma complex and correlates with liver steatosis. J. Hepatol. 2008, 49, 787-798.
40. Kotite, L., Zhang, L. H., Yu, Z., Burlingame, A. L., Havel, R. J., Human apoC-IV: isolation, characterization, and immunochemical quantification in plasma and plasma lipoproteins. J. Lipid Res. 2003, 44, 1387-1394.
41. Willemse, J. L., Hendriks, D. F., Measurement of procarboxypeptidase U (TAFI) in human plasma: a laboratory challenge. Clin. Chem. 2006, 52, 30-36.
42. Petersen, S. V., Thiel, S., Jensenius, J. C., The mannan-binding lectin pathway of complement activation: biology and disease association. Mol. Immunol. 2001, 38, 133-149.
43. Turner, M. W., The role of mannose-binding lectin in health and disease. Mol. Immunol. 2003, 40, 423-429.
44. Vanloo, B., Peelman, F., Deschuymere, K., Taveirne, J. et al., Relationship between structure and biochemical phenotype of lecithin:cholesterol acyltransferase (LCAT) mutants causing fish-eye disease. J. Lipid Res. 2000, 41, 752-761.
45. Simi, M., Leardi, S., Tebano, M. T., Castelli, M. et al., Raised plasma concentrations of platelet factor 4 (PF4) in Crohn's disease. Gut 1987, 28, 336-338.
46. Vrij, A. A., Rijken, J., Van Wersch, J. W., Stockbrugger, R. W., Platelet factor 4 and beta-thromboglobulin in inflammatory bowel disease and giant cell arteritis. Eur. J. Clin. Invest. 2000, 30, 188-194.
47. Kuriyama, M., Wang, M. C., Lee, C. I., Papsidero, L. D. et al., Use of human prostate-specific antigen in monitoring prostate cancer. Cancer Res. 1981, 41, 3874-3876.
48. Thompson, I. M., Pauler, D. K., Goodman, P. J., Tangen, C. M. et al., Prevalence of prostate cancer among men with a prostate-specific antigen level < or = 4.0 ng per milliliter. N. Engl. J. Med. 2004, 350, 2239-2246.
49. Wolfe, M. L., Rader, D. J., Cholesteryl ester transfer protein and coronary artery disease: an observation with therapeutic implications. Circulation 2004, 110, 1338-1340.
50. Pogue-Geile, K. L., Chen, R., Bronner, M. P., Crnogorac-Jurcevic, T. et al., Palladin mutation causes familial pancreatic cancer and suggests a new cancer mechanism. PLoS Med. 2006, 3, e516.